TY  - JOUR
AU  - Tamargo Menéndez, Juan
AU  - Caballero Collado, Ricardo
AU  - Gómez García, Ricardo
AU  - Núñez Fernández, Lucía
AU  - Vaquero González, Luis Miguel
AU  - Delpón Mosquera, María Eva
PY  - 2007
DO  - 10.1016/j.pharmthera.2006.12.002
SN  - 0163-7258
UR  - https://hdl.handle.net/20.500.14352/92738
T2  - Pharmacology & Therapeutics
AB  - Inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase (statins) are the most effective and best-tolerated drugs to treat elevated levels of low-density lipoprotein cholesterol (LDL-C). In addition, they exhibit other effects...
LA  - eng
M2  - 107
PB  - Elsevier
KW  - Statins
KW  - Cardiac arrhythmias
KW  - Atrial fibrillation
KW  - Ventricular tachyarrhythmias
KW  - Antiarrhythmic actions
KW  - Pleiotropic effects
TI  - Lipid-lowering therapy with statins, a new approach to antiarrhythmic therapy
TY  - journal article
VL  - 114
ER  -